Below are a few, handpicked key messages for our partners and customers.
Please do let us know if you would like us to arrange a virtual meeting to discuss further.

Yourgene Health has launched its first infectious disease test – a molecular PCR-based COVID-19 assay. The Yourgene Health Clarigene SARS-CoV-2 test is a PCR-based COVID-19 assay to detect SARS-CoV-2 virus RNA targets to confirm the presence of the virus.
IONA® Software and Sage™ Link – our NIPT bioinformatics solutions are well renowned and well respected. Yourgene Flex™ is a modular next-generation sequencing (NGS) analysis framework harnessing best in class bioinformatics pipelines.
Yourgene Genomic Services harnesses Yourgene’s core capabilities to build a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations.
We have created a service business that supports partners at the preclinical, clinical, and post-market stages as they develop, manufacture, obtain regulatory approval and commercialise new products and services.
Elucigene DPYD - the Group’s first oncology product, which is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered.
Our market leading PCR test for Cystic Fibrosis is the only commercially available pan-European Cystic Fibrosis testing kit designed specifically to address most common mutations found across populations of European origin.
Our Taipei service laboratory provides an oncology genetic analysis service with tests available predominantly for lung, colorectal and breast cancer.
World class experience in diagnostic development from launching the first CE-IVD non-invasive prenatal screening to driving companion diagnostic collaborations including FDA approval.
Our global team with extensive expertise, skills and industry knowledge spanning from non-regulated to highly regulated IVD manufacture and kitting capabilities to ensure the right product gets to the right customer on time.
An ever- growing range of products across the reproductive health journey that utilise different technologies, including PCR-based screening tests for Male Factor Infertility, Recurrent Pregnancy Loss and Genetic Thrombosis.
We offer a range of products for the management of reproductive health. We have developed genetic tools to investigate the cause of recurrent miscarriage and male infertility. Our PCR-based screening tests include Male Factor Infertility, Recurrent Pregnancy Loss and Genetic Thrombosis. Our QST*R Rapid Aneuploidy Analysis test can be carried out for Women that have a high-risk first trimester combined test or an NIPT.
Yourgene provides two complementary screening solutions, The IONA® test and the Sage™ prenatal screen, to meet more of our lab customers’, clinicians’ and pregnant women’s needs across different international locations. The IONA® test and the Sage™ prenatal screen.
Yourgene provides two complementary screening solutions to meet more of our lab customers', clinicians' and pregnant women's needs across different international locations.
Publish the Menu module to "offcanvas" position. Here you can publish other modules as well.
Learn More.